MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-28-2026
NeoGenomics Depreciation & Amortization 2011-2026 | NEO
Annual Depreciation & Amortization NeoGenomics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 36.1 M | 39.1 M | 37.4 M | 35.4 M | 30.2 M | 25.9 M | 20.3 M | 15.8 M | 15.6 M | 15.9 M | 6.73 M | 5.34 M | 4.19 M | 3.64 M | 2.08 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 39.1 M | 2.08 M | 19.6 M |
Quarterly Depreciation & Amortization NeoGenomics
| 2026-Q1 | 2025-Q4 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.78 M | - | 8.12 M | 9.37 M | - | 8.36 M | 8.36 M | 9.9 M | - | 8.78 M | 8.78 M | 9.05 M | - | 8.49 M | 8.49 M | 8.4 M | - | 21.8 M | 13.6 M | 6.68 M | - | 18.7 M | 12.2 M | 6.24 M | - | 15.2 M | 10.4 M | 5.27 M | - | 11.5 M | 7.44 M | 3.63 M | - | 11.7 M | 7.91 M | 3.98 M | - | 11.6 M | 7.33 M | 3.58 M | - | 4.97 M | 3.25 M | 1.59 M | - | 3.94 M | 2.4 M | 1.15 M | - | 3.12 M | 2.05 M | 990 K | - | 2.55 M | 1.6 M | 749 K | - | 1.48 M | 963 K | 488 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 21.8 M | 488 K | 7 M |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Co-Diagnostics
CODX
|
1.11 M | $ 1.27 | -22.09 % | $ 1.69 M |  USA |
 |
Fulgent Genetics
FLGT
|
24.9 M | $ 15.81 | -2.35 % | $ 478 M | USA |
 |
Agilent Technologies
A
|
321 M | $ 111.6 | -1.45 % | $ 33.9 B | USA |
 |
Castle Biosciences
CSTL
|
40.8 M | $ 19.18 | 1.59 % | $ 556 M | USA |
 |
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
112 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Illumina
ILMN
|
354 M | $ 141.04 | -1.54 % | $ 22.4 B | USA |
 |
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | USA |
 |
Interpace Biosciences
IDXG
|
425 K | $ 1.8 | - | $ 7.96 M | USA |
 |
CareDx, Inc
CDNA
|
15 M | $ 19.85 | -3.12 % | $ 1.06 B | USA |
 |
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M |  Israel |
 |
Lantheus Holdings
LNTH
|
70.1 M | $ 93.57 | -3.21 % | $ 6.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | USA |
 |
Medpace Holdings
MEDP
|
27.2 M | $ 417.23 | -0.46 % | $ 12 B | USA |
 |
Mettler-Toledo International
MTD
|
51.1 M | $ 1 037.75 | -0.4 % | $ 21.4 B |  Schweiz |
 |
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M |  China |
 |
Myriad Genetics
MYGN
|
53.7 M | $ 3.62 | -0.14 % | $ 335 M | USA |
 |
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
403 M | $ 153.0 | -3.85 % | $ 7.58 B | USA |
 |
National Research Corporation
NRC
|
7.62 M | $ 18.63 | -1.61 % | $ 417 M | USA |
 |
Natera
NTRA
|
16.7 M | $ 188.85 | -4.1 % | $ 18.6 B | USA |
 |
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
125 M | - | - | $ 19.8 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
1.12 B | $ 25.25 | -0.98 % | $ 23.9 B |  Niderland |
 |
Guardant Health
GH
|
39.7 M | $ 94.7 | -4.02 % | $ 11.9 B | USA |
 |
Senseonics Holdings
SENS
|
1.51 M | $ 5.72 | -1.8 % | $ 239 M | USA |
 |
Personalis
PSNL
|
10 M | $ 6.46 | -3.73 % | $ 576 M | USA |
 |
Soleno Therapeutics
SLNO
|
2.02 M | $ 53.0 | 0.02 % | $ 2.69 B | USA |
 |
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
488 M | $ 117.71 | 0.53 % | $ 9.71 B |  Irlanda |
 |
QIAGEN N.V.
QGEN
|
194 M | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
87 K | $ 2.36 | -2.12 % | $ 5.42 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
681 M | $ 252.45 | -0.62 % | $ 21 B | USA |
 |
Thermo Fisher Scientific
TMO
|
1.05 B | $ 438.41 | -2.17 % | $ 165 B | USA |
 |
Celcuity
CELC
|
167 K | $ 135.32 | 0.45 % | $ 6.33 B | USA |
 |
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | Israel |
 |
Twist Bioscience Corporation
TWST
|
24.9 M | $ 48.53 | -8.35 % | $ 2.9 B | USA |
 |
Neogen Corporation
NEOG
|
119 M | $ 8.22 | -2.55 % | $ 1.78 B | USA |
 |
Waters Corporation
WAT
|
88.1 M | $ 330.33 | -0.86 % | $ 19.7 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
570 M | $ 186.95 | -0.53 % | $ 20.8 B | USA |